Piperlonguminine is neuroprotective in experimental rat stroke

International Immunopharmacology

Volumn 23, Issue 2, 2014, Pages 447-451

  Yang, Tiansong ^a   Sun, Shixiao ^a   Wang, Tiegang ^b   Tong, Xin ^c   Bi, Junhui ^a   Wang, Yulin ^a   Sun, Zhongren ^a  

^a HEILONGJIANG UNIVERSITY OF CHINESE MEDICINE   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

^c Atlantic Institute of Oriental Medicine (ATOM)   (United States)

Author keywords

Experimental stroke; Piperlonguminine; Rats; Signaling pathways

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE P38; NEUROPROTECTIVE AGENT; PIPERLONGUMININE; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; 1,3 DIOXOLANE DERIVATIVE; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OXYGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; BLOOD BRAIN BARRIER; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; BRAIN WATER; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; EXPERIMENTAL STROKE; IN VITRO STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; PROTEIN PHOSPHORYLATION; RAT; REPERFUSION; SIGNAL TRANSDUCTION; ANIMAL; CELL LINE; CELL SURVIVAL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; STROKE; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BLOOD-BRAIN BARRIER; BLOTTING, WESTERN; CELL LINE; CELL SURVIVAL; DIOXOLANES; GENE EXPRESSION REGULATION; GLUCOSE; MALE; NEUROPROTECTIVE AGENTS; NF-KAPPA B; OXYGEN; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RATS; RATS, SPRAGUE-DAWLEY; STROKE;

EID: 84912114426     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2014.09.016     Document Type: Article

References (21)

1. E.H. Lo, T. Dalkara, and M.A. Moskowitz Mechanisms, challenges and opportunities in stroke Nat Rev Neurosci 4 2003 399 415
2. G.A. Donnan, M. Fisher, M. Macleod, and S.M. Davis Stroke Lancet 371 2008 1612 1623
3. K.W. Muir, P. Tyrrell, N. Sattar, and E. Warburton Inflammation and ischaemic stroke Curr Opin Neurol 20 2007 334 342
4. K.L. Lambertsen, K. Biber, and B. Finsen Inflammatory cytokines in experimental and human stroke J Cereb Blood Flow Metab 32 2012 1677 1698
5. H. Huang, C.M. Morgan, R.N. Asolkar, M.E. Koivunen, and P.G. Marrone Phytotoxicity of sarmentine isolated from long pepper (Piper longum) fruit J Agric Food Chem 58 2010 9994 10000
6. K.R. Min, K.S. Kim, J.S. Ro, S.H. Lee, J.A. Kim, and J.K. Son Piperlonguminine from Piper longum with inhibitory effects on alpha-melanocyte-stimulating hormone-induced melanogenesis in melanoma B16 cells Planta Med 70 2004 1115 1118
7. S1. Kumar, J. Kamboj, and Sharma S. Suman Overview for various aspects of the health benefits of Piper longum linn. fruit J Acupunct Meridian Stud 4 2011 134 140
8. B.T. Kang, R.F. Leoni, and A.C. Silva Impaired CBF regulation and high CBF threshold contribute to the increased sensitivity of spontaneously hypertensive rats to cerebral ischemia Neuroscience 269 2014 223 231
9. L. Raj, T. Ide, A.U. Gurkar, M. Foley, M. Schenone, and X. Li Selective killing of cancer cells by a small molecule targeting the stress response to ROS Nature 475 2011 231 234
10. K. Minematsu, L. Li, C.H. Sotak, M.A. Davis, and M. Fisher Reversible focal ischemic injury demonstrated by diffusion-weighted magnetic resonance imaging in rats Stroke 23 1992 1304 1310
11. A. Vakili, F. Hosseinzadeh, and T. Sadogh Effect of aminoguanidine on post-ischemic brain edema in transient model of focal cerebral ischemia Brain Res 1170 2007 97
12. M.J. Cipolla, S.L. Chan, J. Sweet, M.J. Tavares, N. Gokina, and J.E. Brayden Postischemic reperfusion causes smooth muscle calcium sensitization and vasoconstriction of parenchymal arterioles Stroke 45 2014 2425 2430
13. J.P. Modi, P.M. Gharibani, Z. Ma, R. Tao, J. Menzie, and H. Prentice Protective mechanism of sulindac in an animal model of ischemic stroke Brain Res 1576 2014 91 99
14. A. Chamorro, and J. Hallenbeck The harms and benefits of inflammatory and immune responses in vascular disease Stroke 37 2006 291 293
15. A. Tuttolomondo, D. Di Raimondo, R. Pecoraro, V. Arnao, A. Pinto, and G. Licata Inflammation in ischemic stroke subtypes Curr Pharm Des 18 2012 4289 4310
16. H. Sandhu, C.B. Xu, and L. Edvinsson Upregulation of contractile endothelin type B receptors by lipid-soluble cigarette smoking particles in rat cerebral arteries via activation of MAPK Toxicol Appl Pharmacol 249 2010 25 32
17. Z.B. Chen, D.Q. Huang, F.N. Niu, X. Zhang, E.G. Li, and Y. Xu Human urinary kallidinogenase suppresses cerebral inflammation in experimental stroke and downregulates nuclear factor-kappaB J Cereb Blood Flow Metab 30 2010 1356 1365
18. O.A. Harari, and J.K. Liao NF-κB and innate immunity in ischemic stroke Ann N Y Acad Sci 1207 2010 32 40
19. A. Desai, N. Singh, and R. Raghubir Neuroprotective potential of the NF-κB inhibitor peptide IKK-NBD in cerebral ischemia-reperfusion injury Neurochem Int 57 2010 876 883
20. C. Nito, H. Kamada, H. Endo, K. Niizuma, D.J. Myer, and P.H. Chan Role of the p38 mitogen-activated protein kinase/cytosolic phospholipase A2 signaling pathway in blood-brain barrier disruption after focal cerebral ischemia and reperfusion J Cereb Blood Flow Metab 28 2008 1686 1696
21. W. Lee, H. Yoo, J.A. Kim, S. Lee, J.G. Jee, and M.Y. Lee Barrier protective effects of piperlonguminine in LPS-induced inflammation in vitro and in vivo Food Chem Toxicol 58 2013 149 157